|
|
Poll Results
What insulin regimen do you or your child use most often?
Insulin Pump Therapy
Pump - NovoLog
36%
262
Pump - Apidra
1%
9
Pump - Humalog
19%
140
Pump - Regular
1%
3
Lantus Basal-Bolus
Lantus & NovoLog
16%
120
Lantus & Apidra
1%
1
Lantus & Humalog
10%
73
Lantus & Regular
1%
3
Levemir Basal-Bolus
Levemir & NovoLog
2%
15
Levemir & Apidra
0%
0 Levemir & Humalog
1%
2
Levemir & Regular
0%
0 NPH-based Therapy
NPH & NovoLog, Humalog or Apidra
7%
55
NPH & Regular
1%
11
Other
Pre-mixed insulin
1%
4
Other insulin regimen
1%
11
I don't use insulin
1%
4
Total votes: 713
What insulin regimen do you or your child use most often?
Poll dates: September 24 - October 1, 2006
Total Votes: 713When we first ran this poll seven years ago in October 1998, the choices of insulin regimen were significantly limited compared with today. Back then, there was no true basal insulin like Lantus, and Humalog, the first engineered rapid acting insulin analog, was new to the marketplace. Kids with diabetes typically took two or three injections per day of a mixture of long acting (usually NPH) and short acting (usually Regular) insulins. Much has changed in the past seven years.
As we learned in our January 2006 poll about insulins used, the use of NPH has dropped to just 7% of people responding, and the use of Regular insulin has dropped to just 3%. The new engineered insulins, which offer clinical benefits (better predictability of action, reduced risk of hypoglycemia) have taken their place, at least among visitors to CWD. The results of this week's poll show a continuing decline in the use of NPH insulin and growth in pump use -- now 58% of respondents.
Of note in this week's poll is the continuing rise in the number of people using NovoLog insulin as their rapid acting insulin. The following graphs illustrate this:
Insulins used in Insulin Pumps. Click for a larger image.
Insulins used in MDI. Click for a larger image.
Download the Excel spreadsheet used to generate these graphs.The table below summarizes the change in use of short acting insulin from September 2005 until September 2006. This data shows an increase in the use of NovoLog and a decrease in the use of Humalog. The use of Apidra remained low.
Answer Sep 2006 Sep 2005 Insulin used in pumps NovoLog 63% 57% Apidra 2% 1% Humalog 34% 41% Regular 1% 1% Short acting insulin used with Lantus or Levemir in MDI NovoLog 64% 52% Apidra 0% 0% Humalog 35% 46% Regular 1% 2%
|
|
|||
Last Updated: Sunday September 16, 2007 12:54:51
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by Children With Diabetes, Inc, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, Privacy Policy, and Safe Harbor Policy.
© Children with Diabetes, Inc. 1995-2013. Comments and Feedback.